Molecular Modeling Suggests Cruzain Specificity for Peptide Primaquine Prodrugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|7|7|528-533

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.7, Iss.7, 2010-08, pp. : 528-533

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Modeling and Docking Application to Evaluate Cruzain Inhibitory Activity by Chalcones and Hydrazides

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 3, 2014-01 ,pp. : 249-255

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Docking Studies Applied to a Dataset of Cruzain Inhibitors

By  

Current Computer - Aided Drug Design, Vol. 14, Iss. 1, 2018-03 ,pp. : 68-78

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Modeling in the Design of Peptidomimetics and Peptide Surrogates

By  

Current Medicinal Chemistry, Vol. 9, Iss. 24, 2002-12 ,pp. : 2209-2229

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Modeling Studies of Peptide Drug Candidates against SARS

By  

Medicinal Chemistry, Vol. 2, Iss. 3, 2006-05 ,pp. : 309-314

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Small Molecule Non-peptide Formyl Peptide Receptor (FPR) Ligands and Molecular Modeling of Their Recognition

By  

Current Medicinal Chemistry, Vol. 21, Iss. 13, 2014-04 ,pp. : 1478-1504

Bentham Science Publishers

Access to resources Recommend Favorite